Clinical Trial Confidentiality Agreement Template for Philippines

1. Third Party Disclosure: Include when confidential information may need to be shared with third parties such as regulators or subcontractors

2. Publication Rights: Include when parties need to address rights to publish clinical trial results or related research

3. Intellectual Property Rights: Include when the clinical trial may generate new IP or when background IP needs protection

4. Personnel Requirements: Include when specific requirements for personnel handling confidential information need to be detailed

5. International Data Transfers: Include when confidential information may be transferred outside the Philippines

6. Insurance and Indemnification: Include when specific risk allocation related to confidential information handling is required

1. Schedule 1 - Description of Clinical Trial: Detailed description of the clinical trial, including protocol number and study title

2. Schedule 2 - Specific Categories of Confidential Information: Detailed list of types of confidential information covered by the agreement

3. Schedule 3 - Authorized Personnel: List of authorized personnel who will have access to confidential information

4. Schedule 4 - Security Protocols: Detailed security measures and protocols for handling confidential information

5. Schedule 5 - Data Privacy Requirements: Specific requirements under Philippine data privacy laws and regulations

6. Appendix A - Form of Confidentiality Undertaking: Template confidentiality undertaking for individual staff members